In an age of drastically increasing autoimmune diseases and inflammation, with cancer rates often triggered by viral infections and environmental influences, pharmacology has not made any significant breakthroughs in recent decades. Especially chronic infections and severely misregulated inflammations leading to significant organ damage, which neither could be contained nor reversed with current medicine, can often only be successfully influenced by INUSpheresis® blood washing. If INUSpheresis® is used preventively, many of these rapidly increasing autoimmune diseases can often be prevented in advance.

INUSpheresis® is one of the most effective methods of root cause analysis and therapy.

Environmental toxins work according to Haber's rule: The longer they act, the more toxic they become. INUSpheresis®, on the other hand, operates according to the laws of thermodynamics, thus allowing detoxification and decluttering based on the number of therapies performed and the time used. This is based on well-known natural laws and is therefore precisely calculable.

With INUSpheresis®/blood washing, we can simultaneously achieve several goals: We specifically flush out environmental toxins in the blood that cause disease and inflammation. In addition, we reduce the remaining inflammation mediators by half with every INUSpheresis®, i.e., we reduce the inflammation per session by approximately 50%. We also filter out malformed autoimmune antibodies and virus particles (e.g., Hepatitis C and HIV). In other words, we are not tackling the rapidly increasing global phenomenon of autoimmune diseases with side-effect-rich "anti" agents, but instead explicitly removing their triggering factors like environmental toxins, inflammation mediators, and malformed autoimmune antibodies.

Because of the osmotic effect that occurs during INUSpheresis®, the aforementioned disease-causing agents are also washed out from the connective tissue, adipose tissue, nerve tissue, eyes, and all internal organs. With the first INUSpheresis®, these disease-causing agents are significantly reduced and can be completely eliminated with repetitions.

The Effectiveness of INUSpheresis® for Chronic Inflammation and Autoimmune Diseases

• One of the greatest benefits of INUSpheresis® is seen in autoimmune, inflammatory rheumatoid arthritis (RA). With each INUSpheresis®, we can reduce the critical inflammation marker CRP by about 50%. We can also significantly reduce numerous other inflammation markers. For many rheumatism patients, one INUSpheresis® session leads to a noticeable improvement in their mobility and a significant reduction in pain.
• A further example of the clinical importance of flushing out the causes of inflammation from the blood and ultimately from the nervous system is polyneuropathy. INUSpheresis® presents a clear and evidence-based indication.
• How important environmental toxins can be is often made clear in Multiple Chemical Sensitivity Syndromes (MCS). Clinical hypersensitivity to many chemicals often decreases as the body is relieved of pervasive, common environmental toxins.
• Chronic Fatigue Syndrome (CFS), when caused by underlying chronic inflammation, can also demonstrate the impact of the inflammatory agents that are washed out with INUSpheresis®.

Special Long Covid Apheresis Therapy

As a result of the cooperation with the University Clinic Dresden, we have been able to develop a special Corona Apheresis cascade therapy module for patients with Long Covid symptoms, which we have incidentally also used successfully for vaccination damage:

A) A lipid apheresis and one day later naturopathic infusions with selected anti-inflammatory and antioxidant infusions.

B) A therapy with INUSpheresis®, with the ability to remove autoimmune antibodies, circulating immune complexes, inflammatory factors, environmental toxins (triggers) and pathogenic proteins. Here, the removal of autoimmune antibodies is crucial. Acetyl glutathione (an antioxidant) and a vitamin preparation are added.

Depending on the patient, stabilization is achieved with an individual medication plan that includes special infusion therapies, whereby the prevention of thrombi (small vessel occlusions) has priority:

• Enzymes and anticoagulants, if corresponding clinical pictures are known.
• Improvement of microcirculation e.g. with gingko infusions.
• Anti-inflammatory infusions, usually 2 therapies are necessary initially, then a repeat after 2-4 weeks.

Moreover, INUSpheresis® has been proven to significantly improve blood circulation in the arterioles and capillaries, i.e., the smallest terminal branches of the arteries. This is precisely where blood pressure is regulated and where crucial processes of metabolism take place. Not only do circulatory disorders like coronary heart disease or cerebrovascular disorders improve, but the blood flow (microcirculation) in all internal organs is also increased, optimizing the nutrient and oxygen supply and simultaneously enabling the removal of accumulated metabolic waste. Particularly, the eyes benefit from this in cases of macular and retinal diseases, as do the kidneys, brain, and heart.

The positive effect of INUSpheresis® also becomes evident in the energy metabolism (improvements in lactate/pyruvate metabolism are observable, along with positive changes in the peroxynitrite metabolism). This can lead to significant improvements in the metabolic pathways of chronic diseases.

The INUSpheresis® available at BIOLOGICUM+ is currently the most effective method to filter environmental toxins, malformed autoimmune antibodies, circulating immune complexes, and inflammation mediators out of the body. It has proven its value in thousands of applications. Our goal is to restore the body's natural regulatory and functional capacity. For us, INUSpheresis® is essential and a fundamental aspect of our root cause therapy.

History of the INUSpheresis^® Procedure

Apheresis (Def.: to remove something, to filter) was first developed and applied in 1956 by the Japanese physician Agishi. The reason for this was the challenges posed by a mercury catastrophe in Japan (Minamata catastrophe). Since that time, apheresis has continuously been improved and is a well-established treatment for lipid disorders (genetic fat disorders), rheumatism, and emergency medicine. The tried and tested method of blood cleaning, apheresis, has been scientifically further developed by the company INUS into INUSpheresis^® since 2002. This advancement allows the rapid and virtually side-effect-free elimination of accumulated toxins and chronic inflammation from the body. INUSpheresis^® is also experiencing a considerable boom in emerging China. Its particular benefit is evident in the rapidly increasing incidence of autoimmune diseases and environmental stressors, where INUSpheresis^® can often provide significant relief. The unique ability to remove malformed autoimmune antibodies (e.g., rheumatism, Hashimoto, polyneuropathy, etc.), inflammatory agents, and disease-causing environmental toxins from the blood is the distinctive strength of INUSpheresis^®. Another significant capability of therapeutic administration is the measurable improvement of blood circulation in the arterial capillaries, which significantly improves oxygen and nutrient supply to tissue and supports the removal of metabolic waste products. The result is an effective and natural revitalization of all tissue.